Davis Polk advised the representatives of the underwriters in the offering. Generation Bio Co. executed its $225.4 million SEC-registered offering of 9,200,000 shares of common stock,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
